title: Small but severe residual hypoperfusion relates to symptomatic hemorrhage even after early perfusion improvement in tissue plasminogen activator therapy.
authors.affiliation: Hokkaido Neurosurgical Memorial Hospita, Sapporo, Japan. abumiya@hnsmhp.or.jp
authors.forename: Takeo
authors.initials: T
authors.lastname: Abumiya
authors.forename: Masahito
authors.initials: M
authors.lastname: Katoh
authors.forename: Takuya
authors.initials: T
authors.lastname: Moriwaki
authors.forename: Masami
authors.initials: M
authors.lastname: Yoshino
authors.forename: Takeshi
authors.initials: T
authors.lastname: Aoki
authors.forename: Hiroyuki
authors.initials: H
authors.lastname: Imamura
authors.forename: Toshimitsu
authors.initials: T
authors.lastname: Aida
authors.forename: Naoki
authors.initials: N
authors.lastname: Nakayama
authors.forename: Kiyohiro
authors.initials: K
authors.lastname: Houkin
mesh_terms: D000368:Aged; D002543:Cerebral Hemorrhage / Q000175:diagnosis / Q000209:etiology* / Q000473:pathology; D002560:Cerebrovascular Circulation / Q000502:physiology; D002561:Cerebrovascular Disorders / Q000150:complications / Q000188:drug therapy*; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006801:Humans; D007091:Image Processing, Computer-Assisted / Q000379:methods; D018810:Magnetic Resonance Angiography / Q000379:methods; D008297:Male; D015912:Thrombolytic Therapy / Q000379:methods; D010959:Tissue Plasminogen Activator / Q000627:therapeutic use*; D016896:Treatment Outcome
chemical_list: D005343:Fibrinolytic Agents; D010959:Tissue Plasminogen Activator